SCHEMBL17089907

SCHEMBL17089907

COC(=O)CCOCCOCCN(CCOCCOCCC(=O)OC(C)(C)C)S(=O)(=O)c1ccccc1[N+](=O)[O-]

nearest known ligand 0.42

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
NR1D1 P20393 2/20 0.42
SLC10A6 Q3KNW5 1/20 0.40
MEN1 O00255 1/20 0.39
KMT2A Q03164 1/20 0.39
PTPN1 P18031 2/20 0.39
TDP1 Q9NUW8 1/20 0.39
F2 P00734 1/20 0.39
PRSS1 P07477 1/20 0.39
PRSS2 P07478 1/20 0.39
PRSS3 P35030 1/20 0.39
CA1 P00915 2/20 0.38
THRB P10828 1/20 0.38
CA12 O43570 1/20 0.38
CA9 Q16790 1/20 0.38
LMNA P02545 2/20 0.37
VCAM1 P19320 1/20 0.37
CA2 P00918 1/20 0.37
MMP1 P03956 1/20 0.37
MMP2 P08253 1/20 0.37
MMP9 P14780 1/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL20089218 0.84 NR1D1 (0.51) NR1D1SLC10A6MEN1KMT2APTPN1
SCHEMBL17089905 0.82 CA1 (0.45) SLC10A6MEN1KMT2APTPN1TDP1
SCHEMBL17089904 0.82 KMT2A (0.46) SLC10A6MEN1KMT2APTPN1TDP1
SCHEMBL17089909 0.82 KMT2A (0.46) SLC10A6MEN1KMT2APTPN1TDP1
SCHEMBL530068 0.82 NR1D1 (0.43) NR1D1MEN1KMT2APTPN1TDP1
SCHEMBL530360 0.81 NR1D1 (0.46) NR1D1MEN1KMT2APTPN1TDP1
SCHEMBL10076735 0.81 NR1D1 (0.42) NR1D1MEN1KMT2APTPN1TDP1
SCHEMBL31618146 0.79 KMT2A (0.46) MEN1KMT2APTPN1F2PRSS1
SCHEMBL16558058 0.76 NR1D1 (0.53) NR1D1MEN1KMT2APTPN1CA1
SCHEMBL29238398 0.76 MEN1 (0.51) SLC10A6MEN1KMT2APTPN1F2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-9139615-B2 High-affinity, dimeric inhibitors of PSD-95 as efficient neuroprotectants against ischemic brain damage and for treatment of pain UNIVERSITY OF COPENHAGEN (DK) 2015-09-22 US disclosed